SODIUM NITRITE INJECTION, USP DIN 02440466
Health Canada record
| Active ingredient(s) | SODIUM NITRITE 30 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | V03AB08 SODIUM NITRITE |
| Original market date | 20-Jul-2016 |
| Current status date | 13-Jul-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Hope Pharmaceuticals Ltd — licence 102231, currently licensed, last inspection rating C (2025-02-06).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 16835 | 2015-04-28 | New Drug Submission (NDS) |
International API supply for SODIUM NITRITE
2 active FDA Drug Master Files.
Request a quote for SODIUM NITRITE INJECTION, USP